Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 3
2010 2
2011 3
2012 2
2013 4
2014 4
2015 3
2016 7
2017 4
2018 5
2019 5
2020 5
2021 9
2022 10
2023 7
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Bevacizumab and diabetic vitrectomy.
Nicholson BP, Barkmeier AJ. Nicholson BP, et al. Among authors: barkmeier aj. Int Ophthalmol Clin. 2014 Spring;54(2):111-26. doi: 10.1097/IIO.0000000000000013. Int Ophthalmol Clin. 2014. PMID: 24613888 Review. No abstract available.
Predictors of Ophthalmology Resident Performance From Medical Student Application Materials.
Tooley AA, Law J, Lelli GJ, Sun G, Godfrey KJ, Tran AQ, Kim E, Solomon JM, Chen JJ, Khan AR, Wayman L, Olson JH, Lee MS, Harrison AR, Espinoza GM, Davitt BV, Tao J, Hodge DO, Barkmeier AJ. Tooley AA, et al. Among authors: barkmeier aj. J Surg Educ. 2024 Jan;81(1):151-160. doi: 10.1016/j.jsurg.2023.10.003. Epub 2023 Nov 30. J Surg Educ. 2024. PMID: 38036387
Risk of hydroxychloroquine retinopathy in the community.
Dabit JY, Hocaoglu M, Moder KG, Barkmeier AJ, Smith WM, O'Byrne TJ, Crowson CS, Duarte-García A. Dabit JY, et al. Among authors: barkmeier aj. Rheumatology (Oxford). 2022 Aug 3;61(8):3172-3179. doi: 10.1093/rheumatology/keab844. Rheumatology (Oxford). 2022. PMID: 34788400 Free PMC article.
Xanthic scotoma.
Kapoor KG, Barkmeier AJ. Kapoor KG, et al. Among authors: barkmeier aj. JAMA Ophthalmol. 2014 Nov;132(11):1354. doi: 10.1001/jamaophthalmol.2014.573. JAMA Ophthalmol. 2014. PMID: 25256032 No abstract available.
78 results